AU2012275417B9 - Device, system and methods for the oral delivery of therapeutic compounds - Google Patents

Device, system and methods for the oral delivery of therapeutic compounds Download PDF

Info

Publication number
AU2012275417B9
AU2012275417B9 AU2012275417A AU2012275417A AU2012275417B9 AU 2012275417 B9 AU2012275417 B9 AU 2012275417B9 AU 2012275417 A AU2012275417 A AU 2012275417A AU 2012275417 A AU2012275417 A AU 2012275417A AU 2012275417 B9 AU2012275417 B9 AU 2012275417B9
Authority
AU
Australia
Prior art keywords
capsule
balloon
expandable member
tissue penetrating
wall
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012275417A
Other languages
English (en)
Other versions
AU2012275417B2 (en
AU2012275417A1 (en
Inventor
Mir Imran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rani Therapeutics LLC
Original Assignee
Rani Therapeutics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47424526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2012275417(B9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rani Therapeutics LLC filed Critical Rani Therapeutics LLC
Publication of AU2012275417A1 publication Critical patent/AU2012275417A1/en
Application granted granted Critical
Publication of AU2012275417B2 publication Critical patent/AU2012275417B2/en
Priority to AU2017206226A priority Critical patent/AU2017206226B2/en
Publication of AU2012275417B9 publication Critical patent/AU2012275417B9/en
Priority to AU2020200413A priority patent/AU2020200413B2/en
Priority to AU2020294353A priority patent/AU2020294353B2/en
Priority to AU2023202150A priority patent/AU2023202150B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring pH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/07—Endoradiosondes
    • A61B5/073—Intestinal transmitters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Optics & Photonics (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2012275417A 2011-06-29 2012-06-27 Device, system and methods for the oral delivery of therapeutic compounds Active AU2012275417B9 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2017206226A AU2017206226B2 (en) 2011-06-29 2017-07-20 Device, system and methods for the oral delivery of therapeutic compounds
AU2020200413A AU2020200413B2 (en) 2011-06-29 2020-01-21 Device, system and methods for the oral delivery of therapeutic compounds
AU2020294353A AU2020294353B2 (en) 2011-06-29 2020-12-31 Device, system and methods for the oral delivery of therapeutic compounds
AU2023202150A AU2023202150B2 (en) 2011-06-29 2023-04-06 Device, system and methods for the oral delivery of therapeutic compounds

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161571641P 2011-06-29 2011-06-29
US61/571,641 2011-06-29
PCT/US2012/044441 WO2013003487A1 (en) 2011-06-29 2012-06-27 Device, system and methods for the oral delivery of therapeutic compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2017206226A Division AU2017206226B2 (en) 2011-06-29 2017-07-20 Device, system and methods for the oral delivery of therapeutic compounds

Publications (3)

Publication Number Publication Date
AU2012275417A1 AU2012275417A1 (en) 2014-01-23
AU2012275417B2 AU2012275417B2 (en) 2017-04-20
AU2012275417B9 true AU2012275417B9 (en) 2017-08-31

Family

ID=47424526

Family Applications (5)

Application Number Title Priority Date Filing Date
AU2012275417A Active AU2012275417B9 (en) 2011-06-29 2012-06-27 Device, system and methods for the oral delivery of therapeutic compounds
AU2017206226A Active AU2017206226B2 (en) 2011-06-29 2017-07-20 Device, system and methods for the oral delivery of therapeutic compounds
AU2020200413A Active AU2020200413B2 (en) 2011-06-29 2020-01-21 Device, system and methods for the oral delivery of therapeutic compounds
AU2020294353A Active AU2020294353B2 (en) 2011-06-29 2020-12-31 Device, system and methods for the oral delivery of therapeutic compounds
AU2023202150A Expired - Fee Related AU2023202150B2 (en) 2011-06-29 2023-04-06 Device, system and methods for the oral delivery of therapeutic compounds

Family Applications After (4)

Application Number Title Priority Date Filing Date
AU2017206226A Active AU2017206226B2 (en) 2011-06-29 2017-07-20 Device, system and methods for the oral delivery of therapeutic compounds
AU2020200413A Active AU2020200413B2 (en) 2011-06-29 2020-01-21 Device, system and methods for the oral delivery of therapeutic compounds
AU2020294353A Active AU2020294353B2 (en) 2011-06-29 2020-12-31 Device, system and methods for the oral delivery of therapeutic compounds
AU2023202150A Expired - Fee Related AU2023202150B2 (en) 2011-06-29 2023-04-06 Device, system and methods for the oral delivery of therapeutic compounds

Country Status (11)

Country Link
EP (3) EP2726141B1 (enExample)
JP (6) JP6101261B2 (enExample)
CN (1) CN103987422B (enExample)
AU (5) AU2012275417B9 (enExample)
CA (2) CA3159845A1 (enExample)
DK (2) DK2726141T3 (enExample)
ES (2) ES2765029T3 (enExample)
IN (1) IN2014CN00338A (enExample)
PL (2) PL3653223T3 (enExample)
PT (2) PT3653223T (enExample)
WO (1) WO2013003487A1 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102770151B (zh) 2009-08-03 2018-07-31 因卡伯实验室有限责任公司 用于刺激肠道内肠促胰岛素产生的吞咽式囊和方法
US8562589B2 (en) 2009-12-24 2013-10-22 Rani Therapeutics, Llc Swallowable drug delivery device and method of delivery
US8846040B2 (en) 2010-12-23 2014-09-30 Rani Therapeutics, Llc Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8980822B2 (en) 2010-12-23 2015-03-17 Rani Therapeutics, Llc Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8764733B2 (en) 2010-12-23 2014-07-01 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809271B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9284367B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10639272B2 (en) 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9861683B2 (en) 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
PL3653223T3 (pl) * 2011-06-29 2021-12-20 Rani Therapeutics, Llc Urządzenie do doustnego dostarczania związków leczniczych
CA2901923C (en) * 2013-03-15 2021-12-07 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
CN104605900B (zh) * 2013-11-04 2017-04-12 上海交通大学医学院附属第九人民医院 一种可同时提供生物附加效应的皮肤扩张器
US11548940B2 (en) 2014-05-15 2023-01-10 Rani Therapeutics, Llc Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10689460B2 (en) 2014-05-15 2020-06-23 Incube Labs, Llc PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
EP3142645A4 (en) 2014-05-15 2017-12-27 Rani Therapeutics, LLC Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
CN104287685B (zh) * 2014-10-08 2016-03-02 南京航空航天大学 弹性杆导向式胶囊内镜机器人驻停及位姿调整装置与方法
CN113546036A (zh) * 2015-05-01 2021-10-26 拉尼医疗有限公司 药物组合物和用于制备包含多肽和/或蛋白质的固体块的方法
CA2984422C (en) * 2015-05-08 2023-10-17 Incube Labs, Llc Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
EP3347050B1 (en) * 2015-09-08 2025-01-15 Rani Therapeutics, LLC Pcsk9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10190894B2 (en) * 2015-12-26 2019-01-29 Intel Corporation Technologies for controlling degradation of sensing circuits
CN105476593B (zh) * 2015-12-30 2019-02-05 中科院合肥技术创新工程院 一种用于检查食管疾病的胶囊内窥镜
EP3426263A4 (en) * 2016-03-09 2019-10-16 Incube Labs, LLC METHOD AND ARTICLE FOR THE DELIVERY OF LIVABLE CELLS IN SOLID TISSUE
IL301683B2 (en) * 2017-05-17 2025-02-01 Massachusetts Inst Technology Self-healing systems and related components and methods
EP4233978A3 (en) * 2017-12-18 2023-11-15 Biograil APS Oral delivery of active drug substances
WO2019135213A1 (en) * 2018-01-03 2019-07-11 Weiss Menachem Peter In-vivo insertable devices having fail-safe evacuation
US10675248B2 (en) 2018-08-14 2020-06-09 Alma Therapeutics Ltd. Expandable pill
KR102047610B1 (ko) * 2018-12-18 2019-11-22 이민우 다수의 소형 주사기 또는 주사부를 갖는 마이크로 니들 장치
MX2021010972A (es) 2019-03-14 2021-10-13 Esocap Ag Forma de dosificacion farmaceutica para la aplicacion a membranas mucosas y metodos para producir las mismas.
CN119733161A (zh) * 2019-10-01 2025-04-01 拉尼医疗有限公司 用于将制剂递送到管腔壁的自定尺寸装置
CN115300774B (zh) * 2022-08-27 2024-01-30 深圳市资福医疗技术有限公司 一种药剂递送装置、释药方法及应用其的释药胶囊
WO2025081031A1 (en) * 2023-10-12 2025-04-17 Boston Scientific Scimed, Inc. Devices, systems, and related methods for delivering agents to body lumens

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070288033A1 (en) * 2006-06-09 2007-12-13 Allergan, Inc. Intragastric balloon retrieval mechanisms
US20100100117A1 (en) * 2008-10-16 2010-04-22 Obalon Therapeutics, Inc. Intragastric device
WO2011079302A2 (en) * 2009-12-24 2011-06-30 Incube Labs, Llc Swallowable drug delivery device and methods of drug delivery

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60129057A (ja) * 1983-12-14 1985-07-10 住友化学工業株式会社 針状固形製剤投与針
DK42093D0 (da) * 1993-04-07 1993-04-07 Bukh Meditec Administrationsmetode
US6638246B1 (en) * 2000-11-28 2003-10-28 Scimed Life Systems, Inc. Medical device for delivery of a biologically active material to a lumen
AU2003288516A1 (en) 2002-12-26 2004-07-22 Given Imaging Ltd. Immobilizable in vivo sensing device
US20050058701A1 (en) * 2003-01-29 2005-03-17 Yossi Gross Active drug delivery in the gastrointestinal tract
RU2334506C2 (ru) 2003-01-29 2008-09-27 И-Пилл Фарма Лтд. Активная доставка лекарственного средства в желудочно-кишечном тракте
US20050038415A1 (en) * 2003-08-06 2005-02-17 Rohr William L. Method and apparatus for the treatment of obesity
JP4526253B2 (ja) * 2003-10-01 2010-08-18 オリンパス株式会社 体内観察装置
DE102004026615A1 (de) * 2004-06-01 2005-12-29 Siemens Ag Vorrichtung und Verfahren zur Freisetzung eines in das Körperinnere eines Patienten geführten therapeutischen Mittels
EP1827387A2 (en) * 2004-12-14 2007-09-05 E-Pill Pharma Ltd. Prolonged transit time of permeability-enhancing drug eluting pill
EP1841490A2 (en) * 2005-01-18 2007-10-10 Koninklijke Philips Electronics N.V. Electronically controlled capsule
US7785291B2 (en) * 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
DE102005032369A1 (de) 2005-07-08 2007-01-11 Siemens Ag Endoskopiekapsel
JP4402648B2 (ja) * 2005-12-16 2010-01-20 オリンパス株式会社 被検体内導入装置
CA2652569C (en) * 2006-05-18 2015-12-22 Tulip Medical Ltd. Bioerodible self-deployable intragastric and non-gastric implants
WO2010093834A2 (en) * 2009-02-12 2010-08-19 Incube Labs, Llc Skin penetrating device and method for subcutaneous solid drug delivery
JP2010273936A (ja) * 2009-05-29 2010-12-09 Tti Ellebeau Inc バルーンカテーテル
US8562589B2 (en) * 2009-12-24 2013-10-22 Rani Therapeutics, Llc Swallowable drug delivery device and method of delivery
PL3653223T3 (pl) * 2011-06-29 2021-12-20 Rani Therapeutics, Llc Urządzenie do doustnego dostarczania związków leczniczych

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070288033A1 (en) * 2006-06-09 2007-12-13 Allergan, Inc. Intragastric balloon retrieval mechanisms
US20100100117A1 (en) * 2008-10-16 2010-04-22 Obalon Therapeutics, Inc. Intragastric device
WO2011079302A2 (en) * 2009-12-24 2011-06-30 Incube Labs, Llc Swallowable drug delivery device and methods of drug delivery

Also Published As

Publication number Publication date
IN2014CN00338A (enExample) 2015-04-03
AU2020294353A1 (en) 2021-02-25
EP2726141A1 (en) 2014-05-07
ES2765029T3 (es) 2020-06-05
PT3653223T (pt) 2021-12-06
WO2013003487A1 (en) 2013-01-03
JP6101261B2 (ja) 2017-03-22
PT2726141T (pt) 2020-02-24
CA2840487A1 (en) 2013-01-03
AU2020294353B2 (en) 2023-01-12
EP2726141A4 (en) 2015-05-06
JP2017113601A (ja) 2017-06-29
JP2019055197A (ja) 2019-04-11
ES2898893T3 (es) 2022-03-09
CA3159845A1 (en) 2013-01-03
PL3653223T3 (pl) 2021-12-20
JP2014520600A (ja) 2014-08-25
DK2726141T3 (da) 2020-03-02
EP3973983A1 (en) 2022-03-30
EP3653223B1 (en) 2021-08-25
JP2024074923A (ja) 2024-05-31
AU2020200413B2 (en) 2020-10-08
AU2020200413A1 (en) 2020-02-13
AU2012275417B2 (en) 2017-04-20
AU2012275417A1 (en) 2014-01-23
AU2023202150A1 (en) 2023-05-04
JP7016387B2 (ja) 2022-02-04
DK3653223T3 (da) 2021-11-15
AU2023202150B2 (en) 2025-02-20
CN103987422A (zh) 2014-08-13
JP2020171801A (ja) 2020-10-22
CA2840487C (en) 2022-09-27
EP3653223A1 (en) 2020-05-20
EP2726141B1 (en) 2019-12-25
AU2017206226A1 (en) 2017-08-03
AU2017206226B2 (en) 2019-10-24
PL2726141T3 (pl) 2020-06-15
JP6742383B2 (ja) 2020-08-19
JP2022044726A (ja) 2022-03-17
CN103987422B (zh) 2017-02-15

Similar Documents

Publication Publication Date Title
AU2023202150B2 (en) Device, system and methods for the oral delivery of therapeutic compounds
AU2023222952B2 (en) Device for oral delivery of therapeutic compounds
US12263325B2 (en) Device, system and methods for the oral delivery of therapeutic compounds
US9149617B2 (en) Device, system and methods for the oral delivery of therapeutic compounds
HK40072041A (en) Device for the oral delivery of therapeutic compounds
HK40071470A (en) Device for oral delivery of therapeutic compounds

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
SREP Specification republished